Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression-Reference-Cited by-同舟云学术

Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression

Published:2020-11 Issue: Volume:260 Page:118423
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Salimifard Sevda,Karoon Kiani Fariba,Sadat Eshaghi Farzaneh,Izadi Sepideh,Shahdadnejad Kolsoom,Masjedi Ali,Heydari Morteza,Ahmadi Armin,Hojjat-Farsangi Mohammad,Hassannia Hadi,Mohammadi Hamed,Boroumand-Noughabi Samaneh,Keramati Mohammad Reza,Jadidi-Niaragh Farhad

Funder

Mashhad University of Medical Sciences

Tabriz University of Medical Sciences

National Institute for Medical Research Development

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference46 articles.

1. . Sanli, O., et al., Bladder cancer. Nature reviews Disease primers, 2017. 3: p. 17022.

2. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018